Top Stories

Curated By Isabella Tang

By Isabella Tang 2026-06-16

Akeso Enrolls First Patient in Innovative Breast Cancer Study with HER3 ADC AK138D1 and Ivonescimab

Akeso has announced the enrollment of the first patient in a Phase Ib/II clinical trial evaluating its next-generation HER3 antibody-drug conjugate AK138D1 in combination with Ivonescimab for breast cancer treatment. This study represents a significant advancement in the company's IO2.0 + ADC2.0 strategy, aiming to improve therapeutic outcomes for patients.

By Isabella Tang 2026-06-15

CK Asset Achieves Record Sale with US$46.2 Million Mid-Levels Penthouse

CK Asset Holdings has set a new benchmark in Hong Kong's luxury real estate market with the sale of a stunning penthouse in the Mid-Levels for US$46.2 million. This transaction marks the highest price for a residential property in the area since 2018, reflecting the ongoing demand for high-end properties in the city.